Pfizer announces Talzenna and Xtandi combination data from phase 3 study
Data show 37% reduction in risk of disease progression or death in men with metastatic castration-resistant prostate cancer treated with TALZENNA plus XTANDI
Data show 37% reduction in risk of disease progression or death in men with metastatic castration-resistant prostate cancer treated with TALZENNA plus XTANDI
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
A pharma industry veteran with over three decades of experience in domestic as well as international markets
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
This clearance allows the company to initiate a clinical trial for patients with an ileal pouch-anal anastomosis
He was previously associated with renowned companies such as Granules India Ltd, Dr. Reddy’s Laboratories ltd & Aptar Group
Two biopharmaceutical experts join SK bioscience to strengthen the future strategies
mRNA-1345 demonstrated vaccine efficacy of 83.7% against RSV lower respiratory tract disease, defined by 2 or more symptoms in older adults
APAC to see a reduction in imported surgical robotics
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Subscribe To Our Newsletter & Stay Updated